AcelRx Pharmaceuticals Insiders
| ACRXDelisted Stock | USD 1.01 0.01 1.00% |
AcelRx Pharmaceuticals employs about 19 people. The company is managed by 5 executives with a total tenure of roughly 32 years, averaging almost 6.0 years of service per executive, having 3.8 employees per reported executive. Break down of AcelRx Pharmaceuticals' management performance can provide insight into the company performance.
| Vincent Angotti CEO CEO, Interim CFO |
AcelRx |
AcelRx Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3222) % which means that it has lost $0.3222 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5112) %, meaning that it created substantial loss on money invested by shareholders. AcelRx Pharmaceuticals' management efficiency ratios could be used to measure how well AcelRx Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.AcelRx Pharmaceuticals Workforce Comparison
AcelRx Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 31,976. AcelRx Pharmaceuticals adds roughly 19.0 in number of employees claiming only tiny portion of equities under Health Care industry.
AcelRx Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AcelRx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on AcelRx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, AcelRx Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Wan over six months ago Acquisition by Mark Wan of 581 shares of AcelRx Pharmaceuticals subject to Rule 16b-3 | ||
Three Arch Management Iv Llc over a year ago Exercise of in-the-money or at-the-money derivative position by Three Arch Management Iv Llc of 117661 shares of AcelRx Pharmaceuticals | ||
Three Arch Management Iv Llc over a year ago Exercise of in-the-money or at-the-money derivative position by Three Arch Management Iv Llc of 2597 shares of AcelRx Pharmaceuticals | ||
Mark Wan over a year ago AcelRx Pharmaceuticals exotic insider transaction detected |
AcelRx Pharmaceuticals Notable Stakeholders
An AcelRx Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AcelRx Pharmaceuticals often face trade-offs trying to please all of them. AcelRx Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AcelRx Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vincent Angotti | CEO, Interim CFO | Profile | |
| Anil Dasu | Chief Officer | Profile | |
| Lawrence Hamel | Chief Devel. Officer | Profile | |
| Pamela MD | Chief CoFounder | Profile | |
| Raffi Asadorian | Chief Officer | Profile |
About AcelRx Pharmaceuticals Management Performance
The success or failure of an entity such as AcelRx Pharmaceuticals often depends on how effective the management is. AcelRx Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AcelRx management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AcelRx management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California. Acelrx Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.
Please note, the imprecision that can be found in AcelRx Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AcelRx Pharmaceuticals. Check AcelRx Pharmaceuticals' Beneish M Score to see the likelihood of AcelRx Pharmaceuticals' management manipulating its earnings.
AcelRx Pharmaceuticals Workforce Analysis
Traditionally, organizations such as AcelRx Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AcelRx Pharmaceuticals within its industry.AcelRx Pharmaceuticals Manpower Efficiency
Return on AcelRx Pharmaceuticals Manpower
| Revenue Per Employee | 93.2K | |
| Revenue Per Executive | 354.2K | |
| Net Income Per Employee | 2.5M | |
| Net Income Per Executive | 9.6M | |
| Working Capital Per Employee | 568.2K | |
| Working Capital Per Executive | 2.2M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |